Monday, September 14, 2026

Samsung’s 176 Million USD Investment in Element Biosciences: What It Means for Precision Medicine in Asia

Samsung Electronics invests $176 million in Element Biosciences, enhancing its position in the precision medicine market with advanced genomic technology.

U.S. to Soften Alcohol Warnings in Dietary Guidelines, Report Says

The U.S. may revise alcohol guidelines, shifting from strict limits to a focus on moderate drinking, boosting the struggling industry.

Lunit to Present 3 Lung Cancer AI Studies at WCLC, Highlighting Potential for Precision Treatment

Lunit will present three studies using its AI biomarker platform Lunit SCOPE IO at WCLC 2026, focusing on links between genetic mutations, the tumor microenvironment and treatment response.

Tag: market

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

SEERS Joins KRX Healthcare Index: What This Means for AI in Medicine

Wearable AI diagnostics firm Cears has been newly included in the KRX Healthcare Index effective from September 11.

How Huons Global is Transforming the Middle East Aesthetic Market with Innovative Products

Huons Group targets the Middle East market by consolidating its aesthetic products, including fillers and botulinum toxin.

CJ ENM Launches K-Content FAST Channels on Amazon Prime Video: What to Expect?

CJ ENM expands collaboration with Amazon Prime Video to broaden the reach of K-content in the U.S. via FAST streaming services.

2026 Hyundai Ioniq 3: Can This EV Conquer Europe’s B-Segment Market?

Hyundai launches the Ioniq 3 electric SUV in Europe, aiming to sell 20,000 units this year and expand its market presence.

Celtrion’s Steqeyma Seizes 16% Market Share in the U.S.: What’s Next for This Autoimmune Treatment?

Celltrion's autoimmune drug Steqeyma surpasses 16% market share in the U.S., accelerating prescription growth and expansion.

“Second-Half Performance to Outpace First Half”… Celltrion Expected to Exceed Full-Year Revenue Target

Celltrion is expected to outperform its first-half results in the second half, driven by new-product growth, European tender wins and stronger demand for high-margin products, potentially allowing it to exceed its full-year targets.

K-Beauty Revolution: How Korean Medical Aesthetic Devices Are Dominating Global Markets

South Korea's skin beauty medical device companies are continuing to grow, focusing on the overseas market.

Neurophet Partners with Elevate Clinic: How AI is Transforming Brain Injury Diagnosis in the US

Neurophet signs supply contracts with Elevate Clinic for Neurophet Aqua and Neurofit Aqua AD Plus in the U.S. market.

L&K Biomed Wins Additional U.S. FDA Approval, Expanding Spinal Implant Options

L&K Biomed has secured additional FDA approval for expanded BluEX-C sizes, giving U.S. physicians more options for cervical spine implants tailored to individual patient anatomy.

How the New BINSA Law Will Transform K-Bio: Opportunities and Challenges for Korean Companies

U.S. Congress is pushing for investment regulations targeting China's biotech industry, impacting global supply chains and local firms.

Noul Secures Health Canada Approval for AI-Powered miLab MAL Malaria Diagnostic Device

AI-based diagnostic company Noul gains approval for malaria diagnostic device in Canada, accelerating its entry into the North American market.

Celltrion Completes Integration of France’s Gifrer, Targets European Pharmacy Network

Celltrion has completed the post-acquisition integration of French health care company Gifrer and plans to use its pharmacy network as a hub for expanding direct sales across Europe.

Celltrion Expands Market Presence With Major Tender Wins in Spain and Portugal

Celltrion is accelerating its expansion in Spain and Portugal through major tender wins, rising prescriptions and a strengthened direct-sales strategy across its biosimilar portfolio.

Zamenix P: The First AI-Driven Kidney Stone Surgery Robot Approved by FDA – A Game Changer in Minimally Invasive Surgery?

ROEN Surgical secures FDA approval for its kidney stone surgery robot, targeting the U.S. medical device market.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.